What the Moss & Oliver 2012 study on rosemary actually showed.

The Moss and Oliver 2012 paper,¹ published in Therapeutic Advances in Psychopharmacology, is among the most-referenced studies on rosemary essential oil and cognition. It deserves a careful summary because the headline version — "rosemary improves memory" — is not what the study found.

What the researchers did

Twenty participants entered a room that had been scented with rosemary essential oil aroma. After a brief period of exposure, the participants completed a series of cognitive tasks designed to measure attention, working memory, and processing speed. Blood samples were taken before and after the cognitive tests to measure plasma concentrations of 1,8-cineole — the primary aromatic compound in rosemary.

What the researchers found

Two things, related to each other.

First, the plasma concentration of 1,8-cineole rose measurably after exposure. The compound was being absorbed into the bloodstream through inhalation, in detectable quantities, in a normal room — not an experimental chamber. This is the part that is genuinely useful: it provides physical evidence that an inhaled aromatic compound is reaching the systemic circulation.

Second, plasma concentrations of 1,8-cineole correlated with task performance. Participants with higher plasma levels of the compound performed faster and more accurately on certain cognitive measures than participants with lower plasma levels.

What the study did not claim

It did not claim that rosemary improves memory. The cognitive measures were specific: speed of completion, accuracy on simple tasks, working memory under load. These are narrow signals. The study sample was small — twenty people — and the effects were modest.

It did not claim that diffusing rosemary at home will make you smarter. It did not claim therapeutic effect. It did not test long-term outcomes.

Why the study still matters

Most aromatherapy research suffers from a structural problem: it's difficult to prove that an inhaled compound is doing anything systemic, because inhalation is hard to dose-control and the compounds are typically present in tiny quantities. The Moss and Oliver paper sidesteps that problem by directly measuring the compound in blood. That is unusual in this field, and it is what makes the study a useful one to cite.

It is also what makes it dangerous to overclaim. The careful version of the result is: exposure to rosemary aroma is associated with measurable blood concentrations of 1,8-cineole, which in turn correlate with modest improvements on specific cognitive tasks. The careless version is: rosemary helps you focus. The first sentence is what the data supports. The second is the marketing version.

We try to use the first.